Exact Mass: 686.5571

Exact Mass Matches: 686.5571

Found 194 metabolites which its exact mass value is equals to given mass value 686.5571, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

CE(20:4(6E,8Z,11Z,14Z)+=O(5))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoate

C47H74O3 (686.5638)


CE(20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:4(6E,8Z,11Z,14Z)+=O(5)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:4(5Z,8Z,11Z,13E)+=O(15))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoate

C47H74O3 (686.5638)


CE(20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:4(5Z,8Z,11Z,13E)+=O(15)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoate

C47H74O3 (686.5638)


CE(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (5Z,8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoate

C47H74O3 (686.5638)


CE(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C47H74O3 (686.5638)


CE(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoate

C47H74O3 (686.5638)


CE(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

DG(20:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-Hydroxy-3-(icosanoyloxy)propan-2-yl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C43H74O6 (686.5485)


DG(20:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/20:0/0:0)

(2S)-3-Hydroxy-2-(icosanoyloxy)propyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C43H74O6 (686.5485)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-2-Hydroxy-3-(icosanoyloxy)propyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C43H74O6 (686.5485)


DG(20:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/20:0)

(2S)-2-Hydroxy-3-(icosanoyloxy)propyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C43H74O6 (686.5485)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-Hydroxy-3-(icosanoyloxy)propan-2-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C43H74O6 (686.5485)


DG(20:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/20:0/0:0)

(2S)-3-Hydroxy-2-(icosanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C43H74O6 (686.5485)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-2-Hydroxy-3-(icosanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C43H74O6 (686.5485)


DG(20:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/20:0)

(2S)-2-Hydroxy-3-(icosanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C43H74O6 (686.5485)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-(icosanoyloxy)propan-2-yl (8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C43H74O6 (686.5485)


DG(20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/20:0/0:0)

(2S)-3-Hydroxy-2-(icosanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C43H74O6 (686.5485)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-2-Hydroxy-3-(icosanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C43H74O6 (686.5485)


DG(20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/20:0)

(2S)-2-Hydroxy-3-(icosanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C43H74O6 (686.5485)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-Hydroxy-3-(icosanoyloxy)propan-2-yl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C43H74O6 (686.5485)


DG(20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/20:0/0:0)

(2S)-3-Hydroxy-2-(icosanoyloxy)propyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C43H74O6 (686.5485)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-2-Hydroxy-3-(icosanoyloxy)propyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C43H74O6 (686.5485)


DG(20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/20:0)

(2S)-2-Hydroxy-3-(icosanoyloxy)propyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C43H74O6 (686.5485)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-Hydroxy-3-(icosanoyloxy)propan-2-yl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C43H74O6 (686.5485)


DG(20:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/20:0/0:0)

(2S)-3-Hydroxy-2-(icosanoyloxy)propyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C43H74O6 (686.5485)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-2-Hydroxy-3-(icosanoyloxy)propyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C43H74O6 (686.5485)


DG(20:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/20:0)

(2S)-2-Hydroxy-3-(icosanoyloxy)propyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C43H74O6 (686.5485)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-Hydroxy-3-(icosanoyloxy)propan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C43H74O6 (686.5485)


DG(20:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/20:0/0:0)

(2S)-3-Hydroxy-2-(icosanoyloxy)propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C43H74O6 (686.5485)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-2-Hydroxy-3-(icosanoyloxy)propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C43H74O6 (686.5485)


DG(20:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/20:0)

(2S)-2-Hydroxy-3-(icosanoyloxy)propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C43H74O6 (686.5485)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-20:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-hydroxy-3-[(18-methylnonadecanoyl)oxy]propan-2-yl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoate

C43H74O6 (686.5485)


DG(i-20:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-20:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-20:0/0:0)

(2S)-3-hydroxy-2-[(18-methylnonadecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoate

C43H74O6 (686.5485)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-20:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-2-Hydroxy-3-[(18-methylnonadecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C43H74O6 (686.5485)


DG(i-20:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-20:0)

(2S)-2-Hydroxy-3-[(18-methylnonadecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C43H74O6 (686.5485)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-20:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-Hydroxy-3-[(18-methylnonadecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C43H74O6 (686.5485)


DG(i-20:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-20:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-20:0/0:0)

(2S)-3-Hydroxy-2-[(18-methylnonadecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C43H74O6 (686.5485)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-20:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-2-Hydroxy-3-[(18-methylnonadecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C43H74O6 (686.5485)


DG(i-20:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-20:0)

(2S)-2-Hydroxy-3-[(18-methylnonadecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C43H74O6 (686.5485)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-[(18-methylnonadecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C43H74O6 (686.5485)


DG(i-20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-20:0/0:0)

(2S)-3-Hydroxy-2-[(18-methylnonadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C43H74O6 (686.5485)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-2-Hydroxy-3-[(18-methylnonadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C43H74O6 (686.5485)


DG(i-20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-20:0)

(2S)-2-Hydroxy-3-[(18-methylnonadecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C43H74O6 (686.5485)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-Hydroxy-3-[(18-methylnonadecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C43H74O6 (686.5485)


DG(i-20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-20:0/0:0)

(2S)-3-hydroxy-2-[(18-methylnonadecanoyl)oxy]propyl (5Z,8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoate

C43H74O6 (686.5485)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-2-hydroxy-3-[(18-methylnonadecanoyl)oxy]propyl (5Z,8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoate

C43H74O6 (686.5485)


DG(i-20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-20:0)

(2S)-2-Hydroxy-3-[(18-methylnonadecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C43H74O6 (686.5485)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-20:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-hydroxy-3-[(18-methylnonadecanoyl)oxy]propan-2-yl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C43H74O6 (686.5485)


DG(i-20:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-20:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-20:0/0:0)

(2S)-3-hydroxy-2-[(18-methylnonadecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C43H74O6 (686.5485)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-20:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-2-Hydroxy-3-[(18-methylnonadecanoyl)oxy]propyl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C43H74O6 (686.5485)


DG(i-20:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-20:0)

(2S)-2-Hydroxy-3-[(18-methylnonadecanoyl)oxy]propyl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C43H74O6 (686.5485)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-20:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-hydroxy-3-[(18-methylnonadecanoyl)oxy]propan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoate

C43H74O6 (686.5485)


DG(i-20:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-20:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-20:0/0:0)

(2S)-3-hydroxy-2-[(18-methylnonadecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoate

C43H74O6 (686.5485)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-20:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-2-Hydroxy-3-[(18-methylnonadecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C43H74O6 (686.5485)


DG(i-20:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-20:0)

(2S)-2-Hydroxy-3-[(18-methylnonadecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C43H74O6 (686.5485)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

CE(20:4(6E,8Z,11Z,14Z)+=O(5))

CE(20:4(6E,8Z,11Z,14Z)+=O(5))

C47H74O3 (686.5638)


   

CE(20:4(5Z,8Z,11Z,13E)+=O(15))

CE(20:4(5Z,8Z,11Z,13E)+=O(15))

C47H74O3 (686.5638)


   

CE(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

CE(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C47H74O3 (686.5638)


   

CE(20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

CE(20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C47H74O3 (686.5638)


   

CE(20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

CE(20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C47H74O3 (686.5638)


   

CE(20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

CE(20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C47H74O3 (686.5638)


   

DG(20:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(20:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C43H74O6 (686.5485)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/20:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/20:0/0:0)

C43H74O6 (686.5485)


   

DG(20:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(20:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C43H74O6 (686.5485)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/20:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/20:0)

C43H74O6 (686.5485)


   

DG(i-20:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(i-20:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C43H74O6 (686.5485)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-20:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-20:0/0:0)

C43H74O6 (686.5485)


   

DG(i-20:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(i-20:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C43H74O6 (686.5485)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-20:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-20:0)

C43H74O6 (686.5485)


   

DG(20:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(20:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C43H74O6 (686.5485)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/20:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/20:0/0:0)

C43H74O6 (686.5485)


   

DG(20:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(20:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C43H74O6 (686.5485)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/20:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/20:0)

C43H74O6 (686.5485)


   

DG(20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C43H74O6 (686.5485)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/20:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/20:0/0:0)

C43H74O6 (686.5485)


   

DG(20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C43H74O6 (686.5485)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/20:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/20:0)

C43H74O6 (686.5485)


   

DG(20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C43H74O6 (686.5485)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/20:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/20:0/0:0)

C43H74O6 (686.5485)


   

DG(20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C43H74O6 (686.5485)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/20:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/20:0)

C43H74O6 (686.5485)


   

DG(20:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(20:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C43H74O6 (686.5485)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/20:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/20:0/0:0)

C43H74O6 (686.5485)


   

DG(20:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(20:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C43H74O6 (686.5485)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/20:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/20:0)

C43H74O6 (686.5485)


   

DG(20:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(20:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C43H74O6 (686.5485)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/20:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/20:0/0:0)

C43H74O6 (686.5485)


   

DG(20:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(20:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C43H74O6 (686.5485)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/20:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/20:0)

C43H74O6 (686.5485)


   

DG(i-20:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(i-20:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C43H74O6 (686.5485)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-20:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-20:0/0:0)

C43H74O6 (686.5485)


   

DG(i-20:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(i-20:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C43H74O6 (686.5485)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-20:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-20:0)

C43H74O6 (686.5485)


   

DG(i-20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(i-20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C43H74O6 (686.5485)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-20:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-20:0/0:0)

C43H74O6 (686.5485)


   

DG(i-20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(i-20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C43H74O6 (686.5485)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-20:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-20:0)

C43H74O6 (686.5485)


   

DG(i-20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(i-20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C43H74O6 (686.5485)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-20:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-20:0/0:0)

C43H74O6 (686.5485)


   

DG(i-20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(i-20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C43H74O6 (686.5485)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-20:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-20:0)

C43H74O6 (686.5485)


   

DG(i-20:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(i-20:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C43H74O6 (686.5485)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-20:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-20:0/0:0)

C43H74O6 (686.5485)


   

DG(i-20:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(i-20:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C43H74O6 (686.5485)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-20:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-20:0)

C43H74O6 (686.5485)


   

DG(i-20:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(i-20:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C43H74O6 (686.5485)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-20:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-20:0/0:0)

C43H74O6 (686.5485)


   

DG(i-20:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(i-20:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C43H74O6 (686.5485)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-20:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-20:0)

C43H74O6 (686.5485)


   

NAOrn 24:4/13:0

NAOrn 24:4/13:0

C42H74N2O5 (686.5597)


   

NAOrn 13:0/24:4

NAOrn 13:0/24:4

C42H74N2O5 (686.5597)


   

NAOrn 26:4/11:0

NAOrn 26:4/11:0

C42H74N2O5 (686.5597)


   

NAOrn 22:3/15:1

NAOrn 22:3/15:1

C42H74N2O5 (686.5597)


   

NAOrn 17:2/20:2

NAOrn 17:2/20:2

C42H74N2O5 (686.5597)


   

NAOrn 18:2/19:2

NAOrn 18:2/19:2

C42H74N2O5 (686.5597)


   

NAOrn 20:4/17:0

NAOrn 20:4/17:0

C42H74N2O5 (686.5597)


   

NAOrn 18:3/19:1

NAOrn 18:3/19:1

C42H74N2O5 (686.5597)


   

NAOrn 15:0/22:4

NAOrn 15:0/22:4

C42H74N2O5 (686.5597)


   

NAOrn 21:1/16:3

NAOrn 21:1/16:3

C42H74N2O5 (686.5597)


   

NAOrn 16:4/21:0

NAOrn 16:4/21:0

C42H74N2O5 (686.5597)


   

NAOrn 11:0/26:4

NAOrn 11:0/26:4

C42H74N2O5 (686.5597)


   

NAOrn 18:4/19:0

NAOrn 18:4/19:0

C42H74N2O5 (686.5597)


   

NAOrn 15:1/22:3

NAOrn 15:1/22:3

C42H74N2O5 (686.5597)


   

NAOrn 16:2/21:2

NAOrn 16:2/21:2

C42H74N2O5 (686.5597)


   

NAOrn 21:2/16:2

NAOrn 21:2/16:2

C42H74N2O5 (686.5597)


   

NAOrn 17:0/20:4

NAOrn 17:0/20:4

C42H74N2O5 (686.5597)


   

NAOrn 20:3/17:1

NAOrn 20:3/17:1

C42H74N2O5 (686.5597)


   

NAOrn 22:4/15:0

NAOrn 22:4/15:0

C42H74N2O5 (686.5597)


   

NAOrn 17:1/20:3

NAOrn 17:1/20:3

C42H74N2O5 (686.5597)


   

NAOrn 24:3/13:1

NAOrn 24:3/13:1

C42H74N2O5 (686.5597)


   

NAOrn 19:2/18:2

NAOrn 19:2/18:2

C42H74N2O5 (686.5597)


   

NAOrn 16:3/21:1

NAOrn 16:3/21:1

C42H74N2O5 (686.5597)


   

NAOrn 19:1/18:3

NAOrn 19:1/18:3

C42H74N2O5 (686.5597)


   

NAOrn 20:2/17:2

NAOrn 20:2/17:2

C42H74N2O5 (686.5597)


   

2,3-di(octanoyloxy)propyl (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate

2,3-di(octanoyloxy)propyl (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate

C43H74O6 (686.5485)


   

2,3-di(nonanoyloxy)propyl (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

2,3-di(nonanoyloxy)propyl (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

C43H74O6 (686.5485)


   

(2-dodecanoyloxy-3-octanoyloxypropyl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

(2-dodecanoyloxy-3-octanoyloxypropyl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C43H74O6 (686.5485)


   

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-octanoyloxypropyl] (9Z,12Z)-hexadeca-9,12-dienoate

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-octanoyloxypropyl] (9Z,12Z)-hexadeca-9,12-dienoate

C43H74O6 (686.5485)


   

[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-octanoyloxypropan-2-yl] (Z)-hexadec-9-enoate

[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-octanoyloxypropan-2-yl] (Z)-hexadec-9-enoate

C43H74O6 (686.5485)


   

(3-nonanoyloxy-2-pentadecanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

(3-nonanoyloxy-2-pentadecanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C43H74O6 (686.5485)


   

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-octanoyloxypropan-2-yl] hexadecanoate

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-octanoyloxypropan-2-yl] hexadecanoate

C43H74O6 (686.5485)


   

(3-octanoyloxy-2-tetradecanoyloxypropyl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

(3-octanoyloxy-2-tetradecanoyloxypropyl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C43H74O6 (686.5485)


   

[3-octanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

[3-octanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C43H74O6 (686.5485)


   

(3-nonanoyloxy-2-undecanoyloxypropyl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

(3-nonanoyloxy-2-undecanoyloxypropyl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C43H74O6 (686.5485)


   

(3-nonanoyloxy-2-tridecanoyloxypropyl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

(3-nonanoyloxy-2-tridecanoyloxypropyl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C43H74O6 (686.5485)


   

(2-decanoyloxy-3-octanoyloxypropyl) (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

(2-decanoyloxy-3-octanoyloxypropyl) (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

C43H74O6 (686.5485)


   

[3-nonanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

[3-nonanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C43H74O6 (686.5485)


   

[3-nonanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

[3-nonanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C43H74O6 (686.5485)


   

2,3-di(decanoyloxy)propyl (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

2,3-di(decanoyloxy)propyl (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C43H74O6 (686.5485)


   

(3-decanoyloxy-2-dodecanoyloxypropyl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

(3-decanoyloxy-2-dodecanoyloxypropyl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C43H74O6 (686.5485)


   

(2-tridecanoyloxy-3-undecanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

(2-tridecanoyloxy-3-undecanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C43H74O6 (686.5485)


   

(3-decanoyloxy-2-tetradecanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

(3-decanoyloxy-2-tetradecanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C43H74O6 (686.5485)


   

[3-decanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

[3-decanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C43H74O6 (686.5485)


   

2,3-di(undecanoyloxy)propyl (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

2,3-di(undecanoyloxy)propyl (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C43H74O6 (686.5485)


   

2,3-di(dodecanoyloxy)propyl (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

2,3-di(dodecanoyloxy)propyl (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C43H74O6 (686.5485)


   

[2-[(Z)-tridec-9-enoyl]oxy-3-undecanoyloxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

[2-[(Z)-tridec-9-enoyl]oxy-3-undecanoyloxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C43H74O6 (686.5485)


   

[1-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] tetradecanoate

[1-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] tetradecanoate

C43H74O6 (686.5485)


   

[3-dodecanoyloxy-2-[(Z)-dodec-5-enoyl]oxypropyl] (9Z,11Z,13Z)-hexadeca-9,11,13-trienoate

[3-dodecanoyloxy-2-[(Z)-dodec-5-enoyl]oxypropyl] (9Z,11Z,13Z)-hexadeca-9,11,13-trienoate

C43H74O6 (686.5485)


   

[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-tetradec-9-enoate

[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-tetradec-9-enoate

C43H74O6 (686.5485)


   

[1-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-3-[(7Z,9Z)-tetradeca-7,9-dienoyl]oxypropan-2-yl] tetradecanoate

[1-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-3-[(7Z,9Z)-tetradeca-7,9-dienoyl]oxypropan-2-yl] tetradecanoate

C43H74O6 (686.5485)


   

[3-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-2-tridecanoyloxypropyl] (Z)-pentadec-9-enoate

[3-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-2-tridecanoyloxypropyl] (Z)-pentadec-9-enoate

C43H74O6 (686.5485)


   

[3-tridecanoyloxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (5Z,8Z,11Z)-tetradeca-5,8,11-trienoate

[3-tridecanoyloxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (5Z,8Z,11Z)-tetradeca-5,8,11-trienoate

C43H74O6 (686.5485)


   

[2-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-3-[(Z)-dodec-5-enoyl]oxypropyl] hexadecanoate

[2-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-3-[(Z)-dodec-5-enoyl]oxypropyl] hexadecanoate

C43H74O6 (686.5485)


   

[1-[(Z)-dodec-5-enoyl]oxy-3-[(7Z,9Z)-tetradeca-7,9-dienoyl]oxypropan-2-yl] (Z)-tetradec-9-enoate

[1-[(Z)-dodec-5-enoyl]oxy-3-[(7Z,9Z)-tetradeca-7,9-dienoyl]oxypropan-2-yl] (Z)-tetradec-9-enoate

C43H74O6 (686.5485)


   

[3-[(Z)-dodec-5-enoyl]oxy-2-tridecanoyloxypropyl] (6Z,9Z,12Z)-pentadeca-6,9,12-trienoate

[3-[(Z)-dodec-5-enoyl]oxy-2-tridecanoyloxypropyl] (6Z,9Z,12Z)-pentadeca-6,9,12-trienoate

C43H74O6 (686.5485)


   

2,3-di(dodecanoyloxy)propyl (7Z,9Z,11Z,13Z)-hexadeca-7,9,11,13-tetraenoate

2,3-di(dodecanoyloxy)propyl (7Z,9Z,11Z,13Z)-hexadeca-7,9,11,13-tetraenoate

C43H74O6 (686.5485)


   

2,3-bis[[(6Z,9Z)-dodeca-6,9-dienoyl]oxy]propyl hexadecanoate

2,3-bis[[(6Z,9Z)-dodeca-6,9-dienoyl]oxy]propyl hexadecanoate

C43H74O6 (686.5485)


   

[3-[(Z)-dodec-5-enoyl]oxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (9Z,12Z)-pentadeca-9,12-dienoate

[3-[(Z)-dodec-5-enoyl]oxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (9Z,12Z)-pentadeca-9,12-dienoate

C43H74O6 (686.5485)


   

[3-dodecanoyloxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (6Z,9Z,12Z)-pentadeca-6,9,12-trienoate

[3-dodecanoyloxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (6Z,9Z,12Z)-pentadeca-6,9,12-trienoate

C43H74O6 (686.5485)


   

[3-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-2-[(Z)-tridec-8-enoyl]oxypropyl] pentadecanoate

[3-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-2-[(Z)-tridec-8-enoyl]oxypropyl] pentadecanoate

C43H74O6 (686.5485)


   

[1-[(Z)-dodec-5-enoyl]oxy-3-[(5Z,8Z,11Z)-tetradeca-5,8,11-trienoyl]oxypropan-2-yl] tetradecanoate

[1-[(Z)-dodec-5-enoyl]oxy-3-[(5Z,8Z,11Z)-tetradeca-5,8,11-trienoyl]oxypropan-2-yl] tetradecanoate

C43H74O6 (686.5485)


   

2,3-bis[[(Z)-dodec-5-enoyl]oxy]propyl (4Z,7Z)-hexadeca-4,7-dienoate

2,3-bis[[(Z)-dodec-5-enoyl]oxy]propyl (4Z,7Z)-hexadeca-4,7-dienoate

C43H74O6 (686.5485)


   

[2-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-3-dodecanoyloxypropyl] (4Z,7Z)-hexadeca-4,7-dienoate

[2-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-3-dodecanoyloxypropyl] (4Z,7Z)-hexadeca-4,7-dienoate

C43H74O6 (686.5485)


   

[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-tridecanoyloxypropyl] (9Z,12Z)-pentadeca-9,12-dienoate

[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-tridecanoyloxypropyl] (9Z,12Z)-pentadeca-9,12-dienoate

C43H74O6 (686.5485)


   

[2-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-3-[(Z)-dodec-5-enoyl]oxypropyl] (Z)-hexadec-7-enoate

[2-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-3-[(Z)-dodec-5-enoyl]oxypropyl] (Z)-hexadec-7-enoate

C43H74O6 (686.5485)


   

2,3-bis[[(Z)-tridec-8-enoyl]oxy]propyl (7Z,9Z)-tetradeca-7,9-dienoate

2,3-bis[[(Z)-tridec-8-enoyl]oxy]propyl (7Z,9Z)-tetradeca-7,9-dienoate

C43H74O6 (686.5485)


   

[1-dodecanoyloxy-3-[(5Z,8Z,11Z)-tetradeca-5,8,11-trienoyl]oxypropan-2-yl] (Z)-tetradec-9-enoate

[1-dodecanoyloxy-3-[(5Z,8Z,11Z)-tetradeca-5,8,11-trienoyl]oxypropan-2-yl] (Z)-tetradec-9-enoate

C43H74O6 (686.5485)


   

[3-dodecanoyloxy-2-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxypropyl] (Z)-hexadec-7-enoate

[3-dodecanoyloxy-2-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxypropyl] (Z)-hexadec-7-enoate

C43H74O6 (686.5485)


   

[3-dodecanoyloxy-2-[(7Z,9Z)-tetradeca-7,9-dienoyl]oxypropyl] (7Z,9Z)-tetradeca-7,9-dienoate

[3-dodecanoyloxy-2-[(7Z,9Z)-tetradeca-7,9-dienoyl]oxypropyl] (7Z,9Z)-tetradeca-7,9-dienoate

C43H74O6 (686.5485)


   

[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (Z)-pentadec-9-enoate

[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (Z)-pentadec-9-enoate

C43H74O6 (686.5485)


   

2-[Carboxy-(2-octadecanoyloxy-3-undecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

2-[Carboxy-(2-octadecanoyloxy-3-undecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C39H76NO8+ (686.5571)


   

2-[Carboxy-(3-dodecanoyloxy-2-heptadecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

2-[Carboxy-(3-dodecanoyloxy-2-heptadecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C39H76NO8+ (686.5571)


   

2-[Carboxy-(3-decanoyloxy-2-nonadecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

2-[Carboxy-(3-decanoyloxy-2-nonadecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C39H76NO8+ (686.5571)


   

2-[Carboxy-(2-pentadecanoyloxy-3-tetradecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

2-[Carboxy-(2-pentadecanoyloxy-3-tetradecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C39H76NO8+ (686.5571)


   

2-[Carboxy-(2-henicosanoyloxy-3-octanoyloxypropoxy)methoxy]ethyl-trimethylazanium

2-[Carboxy-(2-henicosanoyloxy-3-octanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C39H76NO8+ (686.5571)


   

2-[Carboxy-(2-hexadecanoyloxy-3-tridecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

2-[Carboxy-(2-hexadecanoyloxy-3-tridecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C39H76NO8+ (686.5571)


   

2-[Carboxy-(2-icosanoyloxy-3-nonanoyloxypropoxy)methoxy]ethyl-trimethylazanium

2-[Carboxy-(2-icosanoyloxy-3-nonanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C39H76NO8+ (686.5571)


   

TG(40:4)

TG(4:0_16:0_20:4)

C43H74O6 (686.5485)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

TG 10:0_10:0_20:4

TG 10:0_10:0_20:4

C43H74O6 (686.5485)


   

TG 10:0_12:0_18:4

TG 10:0_12:0_18:4

C43H74O6 (686.5485)


   

TG 11:0_11:0_18:4

TG 11:0_11:0_18:4

C43H74O6 (686.5485)


   

TG 4:0_18:2_18:2

TG 4:0_18:2_18:2

C43H74O6 (686.5485)